Wenbo Xu Selected Research

acute flaccid myelitis

12/2021	Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018-2019.
7/2014	Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.
1/2013	Transmission of human enterovirus 85 recombinants containing new unknown serotype HEV-B donor sequences in Xinjiang Uighur autonomous region, China.
12/2010	Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission.
9/2010	Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.
2/2010	Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenbo Xu Research Topics

Disease

15	Infections 12/2022 - 02/2010
14	Measles 10/2020 - 08/2009
12	Poliomyelitis (Polio) 01/2021 - 09/2006
10	COVID-19 12/2022 - 01/2020
8	Rubella (German Measles) 12/2017 - 07/2011
6	acute flaccid myelitis 12/2021 - 02/2010
5	Neoplasms (Cancer) 06/2022 - 04/2011
3	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2018 - 01/2014
2	Paralysis (Palsy) 11/2022 - 09/2006
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
2	Fever (Fevers) 01/2021 - 12/2019
2	Exanthema (Rash) 10/2020 - 01/2018
2	Chickenpox 01/2019 - 10/2016
2	Mumps 11/2018 - 01/2017
1	Lethargy 11/2022
1	Glioma (Gliomas) 11/2022
1	Breakthrough Infections 05/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Triploidy 01/2022
1	Aseptic Meningitis 12/2021
1	Disease Resistance 06/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Diarrhea 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Heart Failure 01/2020
1	Microsatellite Instability 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Rhabdomyosarcoma 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Pneumonia (Pneumonitis) 11/2018
1	Diabetes Mellitus 12/2017
1	Ebola Hemorrhagic Fever 10/2017
1	Herpes Zoster 10/2016

Drug/Important Bio-Agent (IBA)

40	VaccinesIBA 12/2022 - 09/2006
7	NucleotidesIBA 12/2014 - 12/2006
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
5	Neutralizing AntibodiesIBA 12/2022 - 11/2010
5	Immunoglobulin G (IgG)IBA 05/2022 - 12/2017
5	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2016
4	Immunoglobulin M (IgM)IBA 11/2018 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2016
3	Pharmaceutical PreparationsIBA 05/2021 - 04/2011
3	Measles VaccineIBA 10/2020 - 08/2009
3	Rubella VaccineIBA 12/2017 - 02/2012
2	Complement System Proteins (Complement)IBA 11/2022 - 12/2021
2	CytokinesIBA 06/2022 - 09/2011
2	Nucleic AcidsIBA 03/2022 - 01/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 10/2016
2	EnzymesIBA 01/2020 - 01/2018
2	ImmunosorbentsIBA 01/2020 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2013
2	antineoplaston A10 (A 10)IBA 01/2018 - 01/2014
2	Amino Acids FDA Link 12/2016 - 01/2016
1	AntigensIBA 12/2022
1	FurinIBA 12/2022
1	Monoclonal AntibodiesIBA 12/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2022
1	WZ16IBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	COVID-19 VaccinesIBA 05/2022
1	sinovac COVID-19 vaccineIBA 04/2022
1	mRNA VaccinesIBA 04/2022
1	Viral VaccinesIBA 04/2022
1	BNT162 VaccineIBA 04/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Sincalide FDA Link 01/2022
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	matrigelIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 12/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 12/2021
1	Biological ProductsIBA 06/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2021
1	Estrogen Receptor AntagonistsIBA 01/2020
1	BIBP COVID-19 vaccineIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2020
1	ManganeseIBA 12/2019
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Attenuated VaccinesIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	AlkaloidsIBA 01/2019
1	Molecular Probes (Molecular Probe)IBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 12/2017
1	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 05/2017

Therapy/Procedure

1	Immunotherapy 01/2019
1	Therapeutics 01/2019